PMID- 37655721 OWN - NLM STAT- MEDLINE DCOM- 20231225 LR - 20240109 IS - 2050-7518 (Electronic) IS - 2050-750X (Linking) VI - 12 IP - 1 DP - 2023 Dec 22 TI - Mitochondria-targeting nanozyme alleviating temporomandibular joint pain by inhibiting the TNFalpha/NF-kappaB/NEAT1 pathway. PG - 112-121 LID - 10.1039/d3tb00929g [doi] AB - Inflammatory cytokines that are secreted into the spinal trigeminal nucleus caudalis (Sp5C) may augment inflammation and cause pain associated with temporomandibular joint disorders (TMD). In a two-step process, we attached triphenylphosphonium (TPP) to the surface of a cubic liposome metal-organic framework (MOF) loaded with ruthenium (Ru) nanozyme. The design targeted mitochondria and was designated Mito-Ru MOF. This structure scavenges free radicals and reactive oxygen species (ROS) and alleviates oxidative stress. The present study aimed to investigate the effects and mechanisms by which Mito-Ru MOF ameliorates TMD pain. Intra-temporomandibular joint (TMJ) injections of complete Freund's adjuvant (CFA) induced inflammatory pain for >/=10 d in the skin areas innervated by the trigeminal nerve. Tumor necrosis factor-alpha (TNF-alpha), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB), long non-coding RNA nuclear paraspeckle assembly transcript 1 (lncRNA NEAT1), and ROS also have been proved to be significantly upregulated in the Sp5C of TMD mice. Moreover, a single Mito-Ru MOF treatment alleviated TMD pain for 3 d and downregulated TNF-alpha, NF-kappaB, lncRNA NEAT1, and ROS. NF-kappaB knockdown downregulated NEAT1 in the TMD mice. Hence, Mito-Ru MOF inhibited the production of ROS and alleviated CFA-induced TMD pain via the TNF-alpha/NF-kappaB/NEAT1 pathway. Therefore, Mito-Ru MOF could effectively treat the pain related to TMD and other conditions associated with severe acute inflammatory activation. FAU - Bai, Qian AU - Bai Q AD - Medical Research Center, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China. FAU - Zhou, Yaoyao AU - Zhou Y AD - Medical Research Center, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China. FAU - Cui, Xiaona AU - Cui X AD - Medical Research Center, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China. AD - Department of Critical Care Medicine, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. liuxiaojunzzu@163.com. FAU - Si, Haichao AU - Si H AD - Department of Anesthesiology, Nanyang Central Hospital, Nanyang, Henan, China. FAU - Wu, Tingting AU - Wu T AD - Medical Research Center, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China. FAU - Nasir, Abdul AU - Nasir A AD - Medical Research Center, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China. AD - Department of Anesthesiology and Perioperative Medicine, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. FAU - Ma, Heng AU - Ma H AD - Medical Research Center, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China. AD - Department of Anesthesiology and Perioperative Medicine, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. FAU - Xing, Junyue AU - Xing J AD - National Health Commission Key Laboratory of Cardiovascular Regenerative Medicine, Heart Center of Henan Provincial People's Hospital, Central China Fuwai Hospital of Zhengzhou University, Fuwai Central China Cardiovascular Hospital & Central China Branch of National Center for Cardiovascular Diseases, Zhengzhou, Henan, 451464, China. tangpku_zzuhao@zzu.edu.cn. FAU - Wang, Yingying AU - Wang Y AD - National Health Commission Key Laboratory of Cardiovascular Regenerative Medicine, Heart Center of Henan Provincial People's Hospital, Central China Fuwai Hospital of Zhengzhou University, Fuwai Central China Cardiovascular Hospital & Central China Branch of National Center for Cardiovascular Diseases, Zhengzhou, Henan, 451464, China. tangpku_zzuhao@zzu.edu.cn. FAU - Cheng, Xiaolei AU - Cheng X AD - National Health Commission Key Laboratory of Cardiovascular Regenerative Medicine, Heart Center of Henan Provincial People's Hospital, Central China Fuwai Hospital of Zhengzhou University, Fuwai Central China Cardiovascular Hospital & Central China Branch of National Center for Cardiovascular Diseases, Zhengzhou, Henan, 451464, China. tangpku_zzuhao@zzu.edu.cn. FAU - Liu, Xiaojun AU - Liu X AD - Department of Critical Care Medicine, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. liuxiaojunzzu@163.com. FAU - Qi, Shaoyan AU - Qi S AD - Department of Critical Care Medicine, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. liuxiaojunzzu@163.com. FAU - Li, Zhisong AU - Li Z AD - Department of Anesthesiology and Perioperative Medicine, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. FAU - Tang, Hao AU - Tang H AUID- ORCID: 0000-0001-5401-7295 AD - National Health Commission Key Laboratory of Cardiovascular Regenerative Medicine, Heart Center of Henan Provincial People's Hospital, Central China Fuwai Hospital of Zhengzhou University, Fuwai Central China Cardiovascular Hospital & Central China Branch of National Center for Cardiovascular Diseases, Zhengzhou, Henan, 451464, China. tangpku_zzuhao@zzu.edu.cn. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20231222 PL - England TA - J Mater Chem B JT - Journal of materials chemistry. B JID - 101598493 RN - 0 (NF-kappa B) RN - 0 (Tumor Necrosis Factor-alpha) RN - 0 (Reactive Oxygen Species) RN - 0 (RNA, Long Noncoding) RN - 0 (triphenylphosphonium) SB - IM EIN - J Mater Chem B. 2023 Dec 6;:. PMID: 38054383 MH - Mice MH - Animals MH - *NF-kappa B/metabolism MH - Tumor Necrosis Factor-alpha/metabolism MH - Reactive Oxygen Species/metabolism MH - *RNA, Long Noncoding/genetics/metabolism MH - Pain/metabolism/pathology MH - Temporomandibular Joint/metabolism/pathology EDAT- 2023/09/01 12:43 MHDA- 2023/12/25 06:41 CRDT- 2023/09/01 07:14 PHST- 2023/12/25 06:41 [medline] PHST- 2023/09/01 12:43 [pubmed] PHST- 2023/09/01 07:14 [entrez] AID - 10.1039/d3tb00929g [doi] PST - epublish SO - J Mater Chem B. 2023 Dec 22;12(1):112-121. doi: 10.1039/d3tb00929g.